Directorate change

Summary by AI ^BETAClose X

PZ Cussons PLC has announced that Sarah Pollard will be stepping down from the Board of Directors on February 13, 2026, and will remain with the company until March 20, 2026, to ensure a smooth transition. This follows a previous announcement made on September 29, 2025.

Disclaimer*

PZ CUSSONS PLC

22 January 2026

Logo Description automatically generated

22 January 2026

PZ CUSSONS PLC

BOARD CHANGE

Further to the announcement on 29 September 2025, PZ Cussons plc ("the Company") confirms that Sarah Pollard will step down from the Board of the Company on 13 February 2026 and will remain with the business until 20 March 2026 to facilitate an orderly handover.

For further information please contact:

Investors

Simon Whittington - IR and Corporate Development Director +44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com +44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

Notes to editors

About PZ Cussons

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK. We employ just under 2,500 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END